story of the week
GI Safety of Celecoxib vs Naproxen in Patients With Cardiothrombotic Diseases and Arthritis After Upper GI Bleeding
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gastrointestinal Safety of Celecoxib Versus Naproxen in Patients With Cardiothrombotic Diseases and Arthritis After Upper Gastrointestinal Bleeding (CONCERN): An Industry-Independent, Double-Blind, Double-Dummy, Randomised Trial
Lancet 2017 Apr 11;[EPub Ahead of Print], FKL Chan, JYL Ching, YK Tse, K Lam, GLH Wong, SC Ng, V Lee, KWL Au, PK Cheong, BY Suen, H Chan, KM Kee, A Lo, VWS Wong, JCY Wu, MH KyawFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.